- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06564571
Artificial Intelligence in Endoscopic Ultrasound
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Endoscopic Ultrasound (EUS) is an equipment where an ultrasound transducer is attached to the tip of the endoscope. When advanced to the stomach the organs outside such as the pancreas and liver can be visualized in great detail. This enables diagnosis of conditions such as pancreatic cancer. However, an endoscopist must undergo training to accurately interpret these ultrasound images.
The investigators are in the process of developing an artificial intelligence system that could potentially interpret EUS images. The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures. Such correlation if established will lead to possible development of an artificial intelligence platform that can diagnose pancreatic diseases. Such development will potentially minimize human error and decrease learning curve to gain proficiency in EUS.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Barbara Broome
- Phone Number: 321-841-4356
- Email: barbara.broome@orlandohealth.com
Study Contact Backup
- Name: Shyam Varadarajulu, MD
- Phone Number: 321-841-2431
- Email: shyam.varadarajulu@orlandohealth.com
Study Locations
-
-
Florida
-
Orlando, Florida, United States, 32806
- Recruiting
- Orlando Health
-
Contact:
- Barbara Broome
- Phone Number: 321-841-4356
- Email: barbara.broome@orlandohealth.com
-
Contact:
- Shyam Varadarajulu, MD
- Phone Number: 321-841-2431
- Email: shyam.varadarajulu@orlandohealth.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age ≥ 18 years
- Any patient undergoing endoscopic ultrasound examination
Exclusion Criteria:
- Age < 18 years
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients undergoing endoscopic ultrasound procedures
Patients will undergo endoscopic ultrasound procedures as planned.
Abnormalities in the pancreas identified by the endoscopist during the endoscopic ultrasound examination will be correlated against those detected by the AI platform.
|
Patients will undergo endoscopic ultrasound procedures as planned.
Abnormalities in the pancreas identified by the endoscopist during the endoscopic ultrasound examination will be correlated against those detected by the AI platform.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of detection pancreatic abnormalities by AI
Time Frame: 1 day
|
Ability of AI to detect pancreatic abnormalities as identified by an endoscopist during EUS examination of the pancreas.
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of detection pancreatic solid mass lesions by AI
Time Frame: 1 day
|
Ability of AI to detect pancreatic solid mass lesions as identified by an endoscopist during EUS examination of the pancreas.
|
1 day
|
|
Rate of detection pancreatic cystic lesions by AI
Time Frame: 1 day
|
Ability of AI to detect pancreatic cystic lesions as identified by an endoscopist during EUS examination of the pancreas.
|
1 day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Shyam Varadarajulu, MD, Orlando Health, Digestive Health Institute
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 24.015.01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.